PLAT and androgen insensitivity syndrome: Chinese patients with acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator (IV rt‐PA) within 4.5 h of symptom onset had similar rates of all‐cause mortality 1‐year post‐AIS compared with non‐reperfusion (11.1% vs. 12.2%, respectively).